Abstract:Background & aims Older adults are at risk for muscle and cognitive function decline during advanced aging, but the underlying metabolic mechanisms and the role of aging-associated chronic morbidities remain unclear. In the present study, we examined whether protein and amino acid kinetics in older adults with and without chronic morbidities are different when 50-70 and 70-90 of age and related to markers of muscle and brain health declines. Methods In a large cross-sectional observational study, 575 older adults from 12 trials (2014-2022) were stratified based on their age (50-70y vs. 70-95y) and the presence of chronic morbidities. The main outcomes were whole-body production (WBP) and interconversions of amino acids by stable amino acid tracers, body composition, and muscle and cognitive performance. Additionally, the association between metabolic markers and muscle and brain health was assessed. Results Overall lower muscle strength, muscle and fat mass, and cognitive function (p<0.03), but no mood disturbances, were found in 70-95y compared to 50-70y older adults. Presence of morbidities was associated with lower muscle strength and mass, and cognitive function, but higher visceral adipose tissue, and mood disturbances (p<0.05). Aging was associated with suppressed WBP of most amino acids, de novo arginine production, and net protein breakdown, but higher myofibrillar protein breakdown (p<0.007). Presence of morbidities was associated with lower WBP of glutamine, glutamate, histidine, isoleucine, phenylalanine, tyrosine, and net protein breakdown, and higher WBP of valine and taurine (p<0.04). Age showed significant negative correlations with WBP of nearly all amino acids, de novo arginine production and net protein breakdown (r: [-0.407, -0.136], p<0.01) but a positive correlation with WBP of myofibrillar protein breakdown (r=0.133, p=0.009). Lean mass showed positive correlations with de novo arginine production and net protein breakdown and WBP of all amino acids except for isoleucine (r: [0.16, 0.799], p<0.005). Worse cognitive performance was positively associated with WBP of tau-methylhistidine and taurine (r: [0.13, 0.141], p<0.04), but negatively associated with WBP of glycine, valine, and net protein breakdown (r: [-0.222, -0.135], p<0.05). Conclusion Comprehensive phenotyping of a large group of older adults revealed differences in metabolic health in response to advanced aging and chronic morbidities. Poor muscle health accompanied by advanced aging was associated with overall metabolic downregulation, except for enhanced myofibrillar (muscle) protein breakdown. Presence of chronic morbidities was further associated with disturbed muscle health, mood, arginine, and taurine pathways, and higher visceral adipose tissue. Therefore, different phenotypes among older adults need to be considered when evaluating therapeutic approaches to improve muscle and brain health.

Age-Dependent Differences in Postprandial Bile-Acid Metabolism and the Role of the Gut Microbiome

Aging Modulates the Effect of Dietary Glycemic Index on Gut Microbiota Composition in Mice

The composition of the gut microbiome differs among community dwelling older people with good and poor appetite

Aging and sarcopenia associate with specific interactions between gut microbes, serum biomarkers and host physiology in rats

The metabolic and endocrine impact of diet-derived gut microbiota metabolites on ageing and longevity

Microbiota and Metabolite Modifications after Dietary Exclusion of Dairy Products and Reduced Consumption of Fermented Food in Young and Older Men

Advanced glycation end products (AGEs) in metabolic disease: linking diet, inflammation and microbiota

Associations of eating rate with postprandial glycaemic and insulin responses, gastric emptying, food and energy intake in older adults (aged ≥65 years)

Age-dependent Changes in GI Physiology and Microbiota: Time to Reconsider?

Su2006 – Fusobacterium Nucleatum May Promote Glycolysis Via Modulating Lncrna in Colorectal Cancer Cells

Augmented gut hormone response to feeding in older adults exhibiting low appetite.

Postprandial Micronutrient Variability and Bioavailability: An Interventional Meal Study in Young vs. Old Participants

In Vitro Metabolic Capacity of Carbohydrate Degradation by Intestinal Microbiota of Adults and Pre-Frail Elderly

Impact of aging on the digestive system related to protein digestion in vivo

Age-related sarcopenia and altered gut microbiota: A systematic review

Understanding the influence of simulated elderly gastrointestinal conditions on nutrient digestibility and functional properties

Impact of high fat diets, prebiotics and probiotics on gut microbiota and immune function, with relevance to elderly populations

Metabolic kinetics and muscle and brain health markers in older adults, and the role of age and presence of chronic morbidities: a large cross-sectional cohort study

Age-Related Changes in the Gut Microbiota Modify Brain Lipid Composition

Mechanisms Linking the Gut-Muscle Axis With Muscle Protein Metabolism and Anabolic Resistance: Implications for Older Adults at Risk of Sarcopenia

Gut microbiota composition correlates with diet and health in the elderly